iBio Logo (EUIPO, 01/02/2024)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark iBio was filed as Figurative mark on 01/02/2024 at the European Union Intellectual Property Office.
It was registered as a trademark on 07/05/2024.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Armillary spheres, planetaria, astronomic orbits, atomic models, molecular models #Letters surmounted by a sign of disproportionate size
| Trademark form | Figurative mark |
| File reference | 018970179 |
| Application date | January 2, 2024 |
| Publication date | March 28, 2024 |
| Entry date | July 5, 2024 |
| Expiration date | January 2, 2034 |
Trademark owner
8800 HSC Parkway
77807 Bryan
US
77807 Bryan
US
Trademark representatives
Kungsbroplan 3
112 27 Stockholm
SE
goods and services
42
Pharmaceutical peptide, protein, antibody, and chimeric antibody or protein drug development services; pharmaceutical peptide, protein, antibody, and chimeric antibodies or proteins product development; pharmaceutical research and development of peptides, proteins, antibodies, and chimeric antibodies or proteins; conducting early evaluations in the field of new peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals; development of peptide, protein, antibody, and chimeric antibody or protein based pharmaceutical preparations and medicines; laboratory peptide and protein based research services relating to pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development of peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals for the treatment of age-related diseases and cancer; research in the field of peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals; research on the subject of peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals; technical research in the field of peptide, protein, antibody, and chimeric antibody or protein based pharmaceutical studies; testing, inspection or research of pharmaceuticals, cosmetics or foodstuff made with peptides, proteins, antibodies, and chimeric antibodies or proteins; research and development in the pharmaceutical and biotechnology fields; research and development regarding pharmaceuticals, proteins, and antibodies; platform-as-a-service (PaaS) providing a platform for protein analysis and discovery of antibody-based drugs; software as a service (SAAS) services featuring software for designing molecule libraries for the purposes of generating products in the field of pharmaceuticals, biotechnology, and medicine; computer software development in the field of artificial intelligence, biotechnology, pharmaceuticals, and medical applications; laboratory research services relating to pharmaceuticals; medical and scientific research in the field of cancer treatment and diagnosis; providing information on the subject of scientific research in the field of biochemistry and biotechnology; providing on-line non-downloadable software using artificial intelligence for use in facilitating product development in the field of biotechnology, pharmaceuticals, and medicine; scientific research for medical purposes in the area of cancerous diseases; software as a service (SAAS) services featuring software using artificial intelligence for use in facilitating product development in the field of biotechnology, pharmaceuticals, and medicine; technical consulting in the field of pharmaceutical studies; technology consultation in the field of artificial intelligence; testing of pharmaceuticals; testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; providing medical testing services and information in the field of cancer research and disease classification; Providing information about the use of artificial intelligence in medical research in the field of medical biotechnology, and pharmaceuticals
ID: 11018970179